Вы находитесь на странице: 1из 158

2011 .

, 7 (102)

- 7 (102)
1997 .


..
:
..
.. (. . ), .. ,
.. (. ),
.. , .. , .. ,
.. , .. , ..
:
.. (. ), .. (. ),
.. (. ), .. (. ),
.. (. ), .. (. ),
.. (. ), .. (. ),
.. (. ), .. (. ),
.. (. ), .. (. ),
.. (. )
:
050008, . , . , 66.
.: 8 (727) 375-80-57, 8 (727) 375-14-74. : 8 (727) 375-05-29.
E-mail: albina.sb@mail.ru

.
471 27.03.97.

050022, . , . , 98,
./ 260-67-08
.-. . 17,5. 701001/16. 500 .

.
..

, 2011
2

.. .
: ( ) .....................................................................5
.. . ..............................................................12
.. , .. , .. , .. ,
.. , .. , .. , .. , .. .

.............................................................................................................16
.. .
.............................................................................................20
.. .
.................................................................24
.. , .. , .. , .. . .......................................................................................26
.. .
.................................................................. 30
.. , .. , .. , .. .
..............................................................................................................35
.. , .. , .. .
.............................................................37
.. , .. , .. , .. , .. ,
.. , .. , .. . .
(20002009 ..) ..........................................................................................40
.. . -
20052010 ..............................................................................................................................45
.. , .P. . () ......................................................................................................................49
.. .
....................................................51

.. . ...............................................................................................................56
.. .
....................................................................................................................................................58
.. . ..................................61
.. . ....................................................64
.. .
.............................................................................................................................................67
.. . ...............70
.. , .. , .. , . ,
.. . ...............................................72
.. . ..........................75
.. . 2010 ..............................................................77
.. .
2010 ....................................................................................................79
.. C, .. , .. .
...................................................81
.. . .....................................................................83
.. . .................................................................86
3

.. .
............................................................................................................88
.. . .......................................................................................................................................91
.. , .. . llergyscreen
...............................................................................................................94
.. . ...............................................................................................................................96
.. .
..................................................................................................................................................99
.. .
.............................................................................................101
.. , .. , .. , .. ,
.. .
.............................................................................................................................................104
.. . : , , , .......106
.. .
20082010 . ..................................................................................................................110
.. . - ......112
.. . - ......................................................116
.. . ........................................................................................................................119
.. . -
........................................................................122
.. .
, ............................125
.. .
................................................................................................................................127
.. . ............. 129
.. . ...131
.. . ................................................................. 133
.. . ............................................................................................................135
.. . - ......................................................................................................................................139
.. . Helicobacter pylori .....................................................................................................................141
.. . ........................................................................................................................143
.. , . , .. , .. . ......................................................................146
.. . ...149
.. , .. . - .........................................................................151
.. . - ........153
.. . ...155

. . . ....................................................................................................................158

618.145-007.415-053.5/.81-036.1-07-085


2011, 7 (102)

..



( )
. ..

,
, , [1, 2, 3].
,
[2, 4].
: , - ;
, ;
[1, 2]. , ,
41,4 88,4% [1, 2, 5, 6]. 60% , 81,688,3%, 335%
[1, 2, 5]. 54% , 24% ,
4% [5].
,
,
,
[1, 2]. . 11,5
.
, , , ,
, . [6]. () E F
, , ,
.
, II
[6]. , 4570% -
, . [7, 8].
12% 1113
5

54% 2021 [7, 9]. .. i, -


66,7% , 56,9%, 9,7%, 47,2%
[10]. - ; ;
; [10]. ..
5,6% [11].
-
[1, 2]. ( ), , .
, , - [1].

() [12, 13]. ,
, , 81 97% [12, 13, 14].
80 90% , 85 87% [1, 14]. 2
, [15, 16, 17]. , - , [14, 15, 16]. ..
,
[1]. .. [10],
. [1]:
7 , ;
; ;
510 ; . 70%
[1, 13, 14]. , ,
, 63 95% [13, 14, 15].
48 80,6% , 13,834,0%,
16,0% 2,0% [1, 13, 14].
1 , 0,3 , - [14], 23 ,
,
0,20,6 , , 6

,
[1].
2540% .

1015 . : , ; ;
[14].

[18]. ( , , ), ,
( , ), .
, . , . ,
32,2 91,4% [12, 18].

-- () ().
96% 85,9% .
, [1].
, ,
79,2%. 52,6 66,8% [12].
, , ,
, .
. ,
[12].
-- . ,
, .
, ,
, . 90%, 98%
96% [1]. - 2-
, . 1-

. 7

-. -
TR/TE-
TR/TE-.
, 1, ,
,
2 [19].
[3, 20, 21, 22].
,
: , ,
[21, 22, 23]. 94,997,6% [23, 24].
,
, , , , [24, 25],
. : , ; ; 10
[22, 23].
4753% [8].
- , [23]. G.D. Davis 86% ,
16,6 [8]. [5] 12 , , ,
.
. - ,
[5].
.
. ..
, 94% [26]. ..
[1].
, [27]. -125 , , [27].
-125 , [27, 28]. .. , -125
100% [28]. 8

.. [27] 125 36% 12- 88% 34-


. - ,
.
. -125 -,
-125 - [29, 30].
, -125
, , , [29, 30].
( , ) : , . , ,
[31]. ..
.. , -
,
24- ( 23 ),
24- .
,
, ,
, [32]. -
,
.
, , ,
.

1. .., .., .. . .: , 2006. 416 .
2. .., .., .. . .:
, 2002. 452 .
3. David ., Redwine M.D. Laparoscopic approach to the diagnosis of endometriosis.//.
: . ., 1996. . 128133.
4. .. .// . .,
2000. . 1112.
5. .., ..
. // . 1996. 5.
. 812.
6. .. ().// .
.. .: , 2000. . 245260.
7. Laufer M.R., Goitein L., Bush M., Cramer D.W. and Emans S.J. Prevalence of endometriosis
in adolescent women with chronic pelvic pain not responding to conventional therapy.//J. Pediatr.
Adolesc. Gynecol. 1997. 10. P. 199202.
9

8. Davis G.O., Thillet E., Lindemann J. Clinical characteristics of adolescent


endometriosis.//J. Adolesc. Health. 1993. Vol. 14. P. 362368.
9. Laufer M.R., Goldstein D.P. Pelvic pain, dysmenorrhea and premenstrual syndrome.//In:
Pediatric and Adolescent Gynecology. IVth edition. Boston, Little Brown. 1998. P. 363410.
10. i .. i ii, i i i i ii i: . . . . , 2002. 143 .
11. .. - : . ... . . : 14.00.01. , 2006. 27 .
12. .., .. .// . 2000. 1. . 4853.
13. ..
: . - . . ., 2005. 367 .
14. Patel M.D., Feldstein V.A., Chen D.C. at al. Endometriomas. Diagnostic performance of
US.//Radiology. 1999. Vol. 210, 3. P. 739745.
15. .. . .: ,
2002. 247 .
16. .. . .// . . .. .: , 1997. . 3942.
17. .., .., .. . : . 1997. 111 .
18. .., .. : . .: . 1997. 36 .
19. .., .., .., .. ,
-
.// . 1997. 3. . 3640.
20. ..
: .// . .. .
.: , 2000. 32 .
21. .., .., .., .., ..
.// . 1996. 5. . 2324.
22. .., .., .., .., .., ..
.// . 1999. 4. . 2529.
23. .., .. .//. : . ., 1996. . 363364.
24. .., .., .., .., .. .// . 2000. 1. . 1923.
25. .., .. .//
. 1997. 6. . 911
26. .., .., .. .
.//. : . ., 1996. . 145146.
27. .., .., .., .. . -125, -19-9
.//
. 1995. 5. . 2528.
28. .. - ,
: . ... - . : 14.01.01. , 1990. 280 .
29. .., .., .., ..
.// . 1995. 5. . 3537.
10

30. .. , : . - . . ., 1995. 24 .
31. .., .., .. -. , 1998. 121 .
32. .., .. -
: . , 2002. 32 .

..


( )
, 4570% . , , , ,
.

..

( )

,
. .
Summary
S.M. Saduakasova
Modern methods of diagnosis genital endometriosis
juvenile age in girls
(Review)
High information of modern research methods to diagnose endometriosis at an early stage to
estallish the location, distribution of endometriosis, which is important for the choice of treatment
strategy, especially in yong patients.

11

616.53.2


2011, 7 (102)
..

8, - , .

, , . :
; ; .
, . ,
. .
,
, .
.
. , . . , .
-
, .
, , . , ,
, () .
, , , .
.
.
, .
, . , , , ,
.
, ,
. ,
, , . .
, .
, ,
, . ,
, , .
,
, . ,
12

, - .
, , , . ,
, ;
; , . ,
, - .
, , , . , , , . , , ; ; (, ,
. .)
, ,
, .
.
-, , D, E.
, .
, , ; ,
, , , . ( ,
, , ) . D
, , , , ;
, . (, , ) (, )
. .
. , , 1:1:4. (1)
1

,
(/)

6 11

2350

77

79

335

11

2713

90

92

383

, .



(),
610

(),

1118 610

1118

(-)

80

120

80

120

150

200

150

200

15

20

15

20

13

2
1

45

50

45

50

15

20

15

20

250

250

188

188

350

400

280

320

()

200

200

185

185

() , . .

15

20

15

20

10

, , . .

200

200

200

200

11

( ) 1 .

77 (95)

86 (105)

70

78

12

1 (
1 . /)

40 (51)

60 (76)

35

53

13

60

80

58

77

14

15

20

14,7

19,6

15

( 2,53,2%)

300

300

300

300

16

(
2,53,2%)

150

180

150

180

17

( 9%)

50

60

50

60

18

10

12

9,8

11,8

19

(
15%)

10

10

10

10

20

30

35

30

35

21

15

18

15

18

22

1 .

1 .

40

40

23

40

45

40

45

24

10

15

10

15

25

0,4

0,4

0,4

0,4

26

1,2

1,2

1,2

1,2

27

28

.

: .

. 1- : (25%
) 7.30, (1520%
) 11.0012.00, (3540% ) 15.00
16.00 ( 20% ) 20.00.
2- : 1- 8.00,
12.0013.00, 16.00, 20.00.
14


( )

( )

6 11

11

(, , ,
, )

150200

200250

(, , , ,
, .)

200

200

60100

100150

()

200250

250300

, (, ), ,

80120

100120

150200

180230

100

100

, .
, , , . ,
,
. , . , ,
.
- .
.
,
, , ,
, .
717 (2).

- .

1. 834 25.10.2010 . - ,
. . 67, 1819.
2. .., .. . .: .
. 144146.
3. .. . ., -, 2010. . 269.

..

.
15


..


.
Summary
S.T. Saduova
Rational nutrition of pupils
The article presents information about the basics of nutrition and the organization of nutrition in
schools.

613.6:61


2011, 7 (102)

.. , .. , .. ,
.. , .. , .. ,
.. , .. , ..



.. , .



,

[1, 2].

(
, , , , )
.
,
, [3].

.
[4].
(90%- ).
57,2% (
42,8%). , , .
[5].
16

,

. 40 , 36 .

.
() ,
.
,
34 10 .
50%- 79 , 30%-
46 , 7,58,3%- 10 .
, 10
30 , 42,5%- 13,9% 2030 .
.

. (50%
36,1% )
.
(<0,05) . , ,
.
, 3 . , .

, , . , ,
. , , ( ,
, ) (25%- ).

.
12 25% 5,6%
.

.


() .
-
,
. , , -
.
,

17

.
68 .
.
42 .
.
,

. 34 .
. ,
, , .

.

(
).
1 , 3 .
, -
.
.
,
.
,
: ?,
, .

(<0,001) (<0,001)

. ,
.
66,6% , 33,4%.
(<0,05).

.

.

.

.

.
.
18

75%
63,6% .
,
.


- , ,


.

1. 18 , 2009 193-IV
, 87 .
2. ( 06.01.2011 .). , , 15 , 2007 . 251-III .
3. .. - .// . . . : , 2007, 15 .
4. .., ..
.//. 2011, 02. 5457 .
5. ..
4//http://confermedic.ru/content/view/480/79/.

.. , .. , .. , .. ,
.. , .. , .. , .. , ..



,
, .
.

.. , .. , .. , .. ,
.. , .. , .. , .. , ..



,
.


.
19

Summary
Toguzbaeva K.K., Bekmagambetova J.D., Abdullaeva G.M., Seyduanova L.B.,
Niyazbekova L.S., Ukibay M.S., Dauletkalieva R.J., Zhunistaev D.D., Saylybekova A.K.,
Umarova M.M., Nurshabekova A.B.
Hygienic assessment of study quality of health
of health workers due to the influence
of the complex social and occupational factors
Thus, the preliminary results of a study on the basis of a questionnaire survey show that working
conditions in conjunction with adverse social factors can influence health providers. However, to make
decisions to improve the health of health workers this conclusion requires a more thorough scientific
approach based on studying and assessing the incidence of health workers.


2011, 7 (102)

613.648
..




"

, -
.


[1]. -
[2].
-,

. , , ,


.
in vitro .
.
,
[3, 4]. , 20

: , ,
.
. 0,1 5,0 :
Y=0,00570,3161 (R2=0,8832) ;
Y=0,00670,3307 (R2=0,8206) ;
Y=50,50,6383 (R2=0,6321)
.
DataFit, 5.0, .

Y (D).
, ,
(), . (D1, D2Dn), - (N1, N2. Ni).
Di Ni Y (Di). ni,
Ni Y (Di).
pi = ni/Ni
Y (D) (Di, pi). , Ni,
Y (D) , , ,
, Do
Y (D) (D) =
Y (Do ).

y
0,025

0,0057

0,3161

0,34

)
21

0,0015

0,00005

0,26

0,0014

0,00005

0,14

b
0,638

b
0,638

. 1. :
) ; ) ; )
.
22


-
. ,
0,025 , 0,34 ; 0,015
0,26 ; 0,0014
0,14 . 0,25 (. 1).
0,026 , 0,35 ; 0,028
0,32 ;
0,0011 0,13 .
0,26 .
, , ,

.

1. Snigireva G., Shevchenko V.//Recent Research activities about the Chernobyl NPP accident in
Belarus, Ukraina and Russia. Kyoto University: Res.Reactor Institute, 2002. P. 256267.
2. ..
, . . . . . . 2003, 36 .
3. Shevchenko V., Snigireva G., Fedorenko B.//The effect of low dose radiation/Ed. E. Burlakova
V. Naidich. Boston: Utrecht. 2004. P. 3049.
4. .., .., .. .
.// . . 2006. . 46.
4. . 447456.

..




in vitro .

..



in vitro
.
23

Summary
K.O. Makhambetov
Mathematical modeling analysis of genetic effects
in uranium production workers
The article presents the results of the study activity to study the dependence of parameters of
cytogenetic analysis in vitro and mathematical modeling of genetic effects.

618.145-007.415-07


2011, 7 (102)
..




. ..

.
50% [1, 2].
[3, 5]. ,
.
, , [17].
.
. 115
, 20092010 . 25 45
32,80,3 . 61 (53,1%)
54 (46,9%) .
5,31,2 ( 1 15 ).
1 10 ( 3,21,6 ).
22 55 ( 30,61,8 ).
, , .
, , ,
, , . (
, ).
, , , 1821- . 24

42 (36,5%) I
, 38 (33,1%) II 35 (30,4%) III . 65
(56,5%) , .
: ,
, ;
. , , , - .
I 46 (40%) , II 8 (6,9%). 97 (85,2%)
. , ,
22 (19,1%) .
15 (13%) , 2 (1,7%) . . 100% .
108 (93,9%) , 7 (6,1%). : 1)
, , ; 2)
6 . 1 .
.
[1, 68]. 52,6%. : 1
; 2 ,
, ,
,
, . , , ,
.
. 12 .

1. .. .//. , . ., 1988. . 6975.
2. .., .., .. . ., -, 2002. 452 .
3. .. .//,
. 2004. 3. . 65.
4. .. . // ,
. 2009. 3. . 4749.
5. .., .. .// . ., 1983. . 7882.
6. Mettler L., Semm K. Three-step-therapy of genital endometriosis.//Medical management of the
endometriosis. New York: Raven, 1986. P. 23347.
25

7. Thomas E.J., Cooke I.D. Successful treatment of asymptomatic endometriosis: does it benefit
infertile women. Br. Med. J.1987. Vol. 294. P. 11171119.

..



.
. 12 .

..



, .
. 12 .
Summary
G.J. Zhatkanbaeva
Evaluating the effectiveness of combined treatment
of infertility in women with external
genital endometriosis
Patients with infertility and external genital endometriosis need active treatment, regardless of the
extent of its distribution. Preference should be given a two-step treatment with drugs antigonadotropnym
in the second stage of treatment. The optimal period of observation after treatment 12 months.

618.3:618.58


2011, 7 (102)

.. , .. , .. , ..

, , .


() . , - [1, 2, 3, 4].
, 6,5% 31,1% . ,
, . , 23 26

.
,
.
, , ,
,
, , .
-, , , ,
[5, 6, 7].
69 . : 18 8,7%; 1935 87,0%; 35 4,3%.
(88,4%)
. 30,4% , 8,7% ,
21,7% , 4,3% .
47,8% , 13% .
47,8%, 43,5%,
8,7%.
, 13% 2227 , 56,5% 2834
, 35 30,5% . 69,6%
, 30,4% . 69,6%
9 (13%) (- ,
, ).
2 39,1% , 34 52,2% 4
17,4% .
, -- 69,6% , 21,7% , III
. 4,3% . , 13,0%
.
28 13,0% , 2834 39,1% , 35 47,8% .
30,4% , 56,5%,
13,0% .
: 500999
13,0%; 10001499 13,0%; 20002499 46,5%.
7 (10,15%) , 1
28 , 5 2834
, .
85,7% ,
, , , .
27

14,3% .
62 , , 8
, (562,5%)
.
,
, 37,5% .
217,4.
59,4%
, 34,8% 5,8%
. ,
, .
34,8% I 44,9% II . 20,3% ,
III , .
,
. ,
, ,
, ,
, ; ,
.
, . , ,
- ,
.
10 50% 78 ,
67 ,
. .

, - ,
, , - . -
. , ,
.
, , ,
, , - .
28

, .
, 59,6% 33,3% , , ,
, . ,
, , . 45,2%
. ,
.
G
20,0% 59,6% . ,

- - .
: - , , , ,
.
.
.
. III 40% I 10% .
21,2% IIIII
,
( III
),
, , . ,

, .

1. .. .//. 2005. . 13. 1. . 3133.
2. .. .// . , 2009. 2. . 5457.
3. .. (, ): . . -. . . ,
2004. 44 .
4. ... : . . . .
. , 2006. 22 .
29

5. Longs A.F., Labarta J.I., Mayayo E. Children born small for gestational age: multidisciplinary
approach.//Pediatr. Endocrinol. 009. l. 6. P. 324325.
6. .., .. : .//. . . 2007; 2: 913.
7. .., .., .., .. ,
.// . ., 2008. 3. 5. 55 .

.. , .. , .. , ..

. 69 , .
217,4. .

.. , .. , .. , ..

.
69 , . 217,4
. .
Summary
G.B.Bapayeva
Perinatal outcome in fetal growth delay
The incidence of intrauterine growth retardation syndrome fetus in pregnant women
increases. Analysis of the 69 stories of familiesof pregnant women showed that a delay in fetal
development is characterized by extremely adverse outcomes for the fetus and newborn. Perinatal
mortality formed 217. It is interesting to search for new innovative methods of antenatal fetal
growth retardation correction.

618.145-007.415-053.5/.81-036.1-07-085


2011, 7 (102)

..



. ..

, .
- . 30

, , -
, , . , , , 20 45% [1, 2].
, 12,246,1% - [3, 4].
,
. 10%.
, ,
, - , [5, 6, 7]. ,
,
. ,
, [8].
,
.

() () . ()
, , .
.
, - [8]. ()
,
( ,
), ,
. , ,
,
.
. ,
,
. ,
.
58
[10]. 31

.
, - ,
.


.
[9]. -

. -
, , .

( - ), .
, , ,
, ,
.
, ,
.
, . ,
,
[10].

-, ,
.

- .
. - 60 ,
( ), 50 (
).

- .
. (350,0%) ,
40,0% (24) , <0,05.
18,3% (11) 6,0% (3) , 15,0% (9) 4,0% (2),
32

15,0% (9) 4,0% (2) , <0,05.


5,0% (3) 8,0% (4) ,
6,7% (4) 8,0% (4) , >0,05.


70,0% (35) 48,3% (29), <0,05.
, 11,7% (7)
2,0% (1) (<0,05),
10,0% (6) 8,3% (5) .
() 1 (1,7%) 1 (1,7%) .
6,7% (4) 4,0% (2).

: 11,7% (7) 10,0% (5) , 10,0% (6) 8,0% (4), 5,0% (3) 4,0% (2), 5,0% (3) 2,0% (1) .
, - , ,
,
,
.
,
- , , .

.
, , -
.
, ,

. , , , ,

.

1. .. , .
. . . . , 2001. 26 .
2. .. -,
. . .
. . , 2000. 26 .
3. .. . . . . . , 2003. 27 .
33

4. .. -. . . . . , 2001. 22
.
5. .., .., .. . .,
, 2002. 452 .
6. .., .. . -.//
- 5, 2006.
7. .. . . . . . . . 2003. 26 .
8. Allaire C. Endometriosis and infertility: a review. J Reprod Med. Vol. 51. 3. 2006.
P. 164168.
9. .., .., ..//. .: , 2006. 416 .
10. i .. i ii, i i i i ii i . . . . , 2002. 143 .

..



60 - , 40,0% (24)
.
(18,3% 6,0%), 15,0% (9) 4,0% (2) ,
15,0% (9) 4,0% (2) .

..



60 - 40% (24)
.
(18,3% 6,0%- ), 15% (9)
4,0% (2 ) , 15% (9) 4,0% (2) .
, 12- , 10-
.
Summary
Sh.M. Saduakasova
Peculiar properties of somatic health of juvenile girls
with genital endometriosis
Postnatal development of girls with endometriosis was characterized by a high frequency of
formation of extragenital pathology, which can be explained by the formation of an immune response
by type of congenital (compensated) immunodeficiency states and leads to the increase of chronic
extragenital pathology. Predisposition to extragenital pathology is a clinical marker of immunodeficiency
states.
34

616-002.5:618.899


2011, 7 (102)

.. , .. , .. , ..

,
- , .

, , . -
1019% .
3764% , , ,
, . 1528%
, . , 510% .
20% . ,
, . - ,
,
, ,
2010 .
.
38 . .
. 2770% ,
. . . 96% . 14%
.
, . , .
. : .
.
,
, .

.
35

. 1.
L 1

. 2.

. 3. L1

. 4. L1


. , .
(, ) ,
.
- 90%
.
,
.
:
1. ,
90% .
2. , .
3.
, , .
36


1. .., .., .., .., ..,
..
.// : , -, 2004. . 738748.
2. Vincent T. DeVita, Jr, Samuell Hellman, Steven A. Rosenberg//Cancer Principles and Practice
of Oncology. Vol. 2 3rd edition. P. 19781985.
3. Tomita K., Kawahara N. et co//Surgical Strategy for Spinal Metastases Spine, vol. 26.
No 3, 2001.
4. Tokuhashi Y., Matsuzaki H., Toriyama S., et al//Scoring system for the preoperative evaluation
of metastatic spine tumor prognosis, -Spine, -15- 1990. pp 11101113.
5. Martin H.E., Ellis E.B. Biopsy by needle puncture and aspiration Ann Surg. 92:139, 19307.
6. Robert Coleman, MD, FRCP. Bone Metastases From Breast Cancer and Other Solid Tumors.//
ASCO 2001, -San Franisco- May 1215-Education Book pp 152163.

.. , .. , .. , ..


.

.. , .. , .. , ..

, i i iii
i .
Summary
T. atikov, . Dyussembayev, B. Izturov, A. Ilyasova
Vertebroplasty spine tumors
After studying of the given material it is possible to offer as a choice method through the skin
vertebroplasticity with the combined treatment of metastasises and tumoral defeats of a backbone.

616 003.8:616811


2011, 7 (102)

.. , .. , ..


,
- , .


.
: ;
; , ;
. 37

, . . 2010
.

. , .
.
41,7 1 .
. ,
. , ,
. ,
, ,
.
. . 1969 . . 14.12.2010
2 .
: () . . 15.12.2010 (Sol. Lidokaini 1% 9 ml) -
() (. 1, 2).

. 1.

. 2.
38

. . .
: , . .

-.
,
. ,
.

1. Balberkin A.V., Kolondaev A.F., Baranetskiy A.L., Snetkov D.A., Khokhrokov G.I., Samochatov
D.N., Buklemishev Yu.V., Shavyrin D.A. Limb Sparing Treatment in Tumor of Proximal Femur.//
Sarcoma. 2006. Suppl. (XIX annual meeting of European Musculo-Skeletal Oncology Society).
ID 246.
2. Altermatt, S. Operative treatment of solitary Bone Cysts with Trycalcium* Phosphate
Ceramic/S. Altermatt, M. Schwobel, J.P. Pochon//EurJ.Pediatr.Surg. 2007. 2. P . 180182
3. Bauer, T.W., Muschler G.F.//Clin. Ortohp. 2008. 371. P. 10-27.
120. Baschang A., von Laer. Indication and Procedure of Benign Bone Cysts in Children and
Adolescents.//Eur. J.Pediatr.Surg. 1991. 1. P. 207209.

.. , .. , ..


,
.
, .

.. , .. , ..


, ii i
ii i. i ii , i i i .
Summary
A.K. Dyussembayev, T.M. Tatikov, B.Zh. Izturov
Application of minimally invasive radiological operations
in orthopedic oncology
The offered way of the osteoplasticity, at osteoblasts can be a choice method. The applied
technique of operative treatment allows stopping a painful syndrome, to stabilize process and to
improve qualities of life of patients.

39

616-036.22


2011, 6 (101)

.. , .. , .. , .. ,
.. , .. , .. , ..
.
(20002009 .)
. ,
. .. ,
-


() , [1].
.
, 2009 ., 1,1
, , 60% 5 .
. 500 000
[2].
, , , .
, [3].
.. ,

, .
(, , . .)
[4].
, ,

.

,
, , . . [5, 6].

. .
.
, .
. 10 ( 2000-
2009 .) . .

69 20.04.2009 . 40


.
(1997), 535 22.04.1985 .
() ,
- - ,
, , ,
. Excel,
, , . t- ( <0,05).
. 2000- 2009 . 4520 , .
45267 . 2001 (776 ),
2009 (147 ).
1.
1. ,
. 2000- 2009 .


. ,
( 2).
2.

41

,
(58,87,7 57,68,4 ), ,
(15,12,1 19,12,6) (<0,05). ,
, , . , .
3. ,
2000- 2009 .

,
. , , , ,
, 10 000 . 1. ,
2001 , 2009-; 3,80,6 10 000 . ,
34 10 000 . ,
, 20002009 .
, .
.
1

10 000

2000

2001

2002

2003

2004

2005

2006

2007

2008

2009

-
Shigella
10 000

6,5

6,9

6,0

2,2

3,0

2,8

2,8

3,4

3,2

1,1

,
Shigella flexneri 2a (36,63% ). . Shigella sonnei (21,8 %); Shigella
flexneri 1a (13,5%). : Shigella flexneri 1b (8,3%);
Shigella flexneri 6 (6,2%); Shigella flexneri 2b (5,8%). 10 16
. .
2.

42

Shigella sonnei

Shigella flexneri 1a

Shigella flexneri 1b

Shigella flexneri 6

Shigella flexneri 2b

Shigella flexneri 3a

Shigella boydii

Shigella flexneri 3b

Shigella flexneri 4 a

Shigella flexneri var. y

Shigella flexneri 4 c

Shigella flexneri 4 b

Shigella flexneri 5 a

Shigella flexneri var. x

21,8%

13,5%

8,3%

6,2%

5,8%

3,0%

2,4%

1,11%

0,88%

0,22%

0,20%

0,09%

0,07%

0,04%

36,3%

Shigella flexneri 2a

,
. 2000- 2009 .

,
, .
. , . - ,
( ).
- .
. . , , .
.

, , .

1. . .

22.04.10 .
2. Diarrhoeal Diseases (Updated February 2009) Diarrhoeal Diseases: Shigellosis.
February. 2009.
3. .., .. . // ., . 1997.
4. .., ., .. . // V . ,1995.
5. , ..
. // VII , . 1997. . 123124.
6. .., .., .. . // .
2002. 3.
43


.. , .. , .. , .. ,
.. , .. , .. , ..
.
(20002009 .)
,
. 2000- 2009 .
4520 . 3,80,6 10 000 .
3 . 16 , Shigella flexneri 2a (36%).
.

.. , .. , .. , .. ,
.. , .. , .. , ..
(20002009)



. 2000 2009 4520 . 10 000 3,80,6 .
3 . 16
Shigella flexnerae 2a (36%) .
.
Summary
B.T. Begeubaeva, M.V. Lankina, G.T. Seiketova, E.T. Aimurzaeva,
T.A. Kim, A.K. Ospanova, A.T. Karbuzova, A.K. Jullaeva
Shigella caused enteric fever in Almaty
over ten-year period (20002009)
The retrospective study of Shigella isolates collected over a 10-year period (20002009) were
done. All of the isolates were received from the feces of patients hospitalized to infectious hospital
of Almaty, Kazakhstan with symptoms of acute intestinal infection. 4 520 serotypes were identified.
Enteric fever caused by Shigella occurred all over the year. In average, 3,80,6 cases for 10,000 people
of Shigella caused enteritis were bacteriologically confirmed. Shigellas were three times more frequently
detected between June and November. Shigella serovar flexneri 2a ranked as the most common serovar
(36%). We plan to continue research for studying biological and epidemiological characteristics of
Shigella in Almaty.

44


2011, 7 (102)

: 340.6_343.982.323
..


-
20052010

. - - ,
(-,
, , .). - , ; , (), ,
,
. - - : ; ; ; ( ); ( ).
-
,
( 1).
:
1) -
2005 2010 ;
2) ;
3) .
-
2005 2010

2005
2006
2007
2008
2009
2010
1.
36
30
43
34
21
41

(11,39%) (9,43%) (14,42%) (9,49%) (7,09%) (12,53%)


2.
141
143
143
151
67
102
(44,62%) (44,96%) (47,98%) (42,17%) (22,63%) (31,19%)
3.
21
27
14
31
28
33

(6,64%) (8,49%) (4,69%) (8,65%) (9,45%) (10,09%)


4.
78
72
50
60
97
77
(24,68%) (22,64%) (16,77%) (16,75%) (32,77%) (23,54%)
5.
22
25
36
61
69
47
(6,96%) (7,86%) (12,08%) (17,03%) (23,31%) (14,37%)

205
10,71%
747
39,04%
154
8,05%
434
22,68%
260
13,59%
45


1
2
6.

7.

3
18
(5,69)
316

4
21
(6,60%)
318

5
12
(4,02%)
298

6
21
(5,86%)
358

7
14
(4,72%)
296

8
27
(8,25%)
327

9
113
5,90%
1913

.
20052010 .
1 , : , ,
, , ,
, , , , , 9,43% ,
. 2007 43 , 14,42%
, . 2008
34 , 9,49% ,
. 2009 21 , 7,09% , . 2010 41 ,
12,53% , . 205 ,
10,71% 20052010 .
2 , , , - () ,
. ,
2005 141 , 44,62% . 2006 143 ,
44,96% , . 2007
143 , 47,98%
, . 2008 151 , 42,17% , . 2009
67 , 22,63% , . 2010 102 , 31,19%
, .
, ,
747, 39,04% 20052010 .
3 , , ,
. ,
,
. , 2005 21 , 6,64% , .
2006 27 , 8,49%
, . 2007 14 ,
4,69% , . 2008 31 , 8,65% , 46

. 2009 28 , 9,45%
, . 2010 33 , 10,09% , .
, , 154, 8,05%
20052010 .
4 , . , 2005 78 ,
24,68% , . 2006
72 , 22,64% , . 2007 50 , 16,77%
, . 2008 60
, 16,75% , .
2009 97 , 32,77%
, . 2010 77 , 23,54% , . 434 ,
22,68% 20052010 .
5 , . ,
2005 22 , 6,98%
, . 2006 25 ,
7,86% , . 2007 36
, 12,08% , .
2008 61 , 17,03%
, . 2009 69 ,
23,31% , . 2010 47 , 14,37% ,
. 260 ,
13,59% 20052010 .
6 , , , , . ,
2005 18 , 5,69%
, . 2006 21 , 6,60% , . 2007
12 , 4,02% ,
. 2008 21 , 5,86% , . 2009 14 ,
4,72% , . 2010
27 , 8,25% , . 113 ,
5,90% 20052010 .
, :
1) 2005 2010 , -
.
47

2)
- , .
3)

.
,
, .

..

-
20052010
-
2005 2010 , () .

..
20052010
-

20052010 - , () ,
.
Summary
O.B. Kim
The Retrospective analysis type physician
of criminal law expert operations for 20052010
The retrospective analysis physician-of criminal law expert operations is Organized for period
with 2005 on 2010, is herewith shown sloppy track record on each type of the expert operations (the
studies) in quantitative and percent correlation.

48


2011, 7 (102)
340.6

.. , JI.P.
()
-

() , , . [1], 313
. 1 13 , 1 20 , 1 38 , 1 250 , . =8,2.

. , 0,01%
0,5 1 , 0,125%, 0,25% 0,5%
, . .

.
[1] 100% 3050%
24 , 20%
4 . .
0,3 5 0,00010,0018 / [2]. 0,075 3 8
0,00030,00035 / [3]. 25
0,025 [4], , 0,0250,027 /.
[5] 0,023 /,
0,024 /, 0,086 /. 1025
.
, .
- . 425 .
[6] - .
, 0,01% .
0,5 3 10% , 1 10% 1 . .
, .
1 10
10% . . 1 10
1 1% 10%
. 15 .
49

( ,
, ).
, ,
.
[7] 5%
10% .
- .
- Sorbfil ()
-1 0,1 0,3; 0,6 1,2 . - (2:3).
. Rf-0,86,
0,6 1,2 , 0,3 .
- 5%
10% , .
-
( ). -
, 4,2 18 , 100 . , .
- Sorbfil ()
-1 0,1 .
- (2:3) .
Rf=0,86, 0,6
. ,
12+KSCN ,
Rf=0,86 : 0,003; 0,03; 0,3 0,6 .
-
0,003 .
:
, 5%
10% -
.
.
- -
, 4,2 18 ()
100 .
. 0,003 .

1. Clarke's. Isolation and Identification of Drugs in pharmaceuticals, body fluids and post-mortem
material. Second Edition, London, The Pharm. Press, 1986.
2. D. Davies et al., Br. J. clin. Pharmac, 1976, 3, 348 .
50

3. A. Kerahen et al., Eur. J. clin. Pharmac. 1978, 13, 97101.


4. J.A. Rotellar et al., Lancet, 1981,1. 1312.
5. I. Lukkari et al., Bull. mt. Ass. forens. Toxicol., 1983, 17(2), 1314.
6. A.A. , .. , .. . () . , 1983, 4, . 3638.
7. S. Goenechea and M. Franke. Kokain, Mitteilung der Senatskommission fur Klinische
Toxicologische Analytik DEG (1993).

A.E. , ..
()
-
, .

.. , ..
-
()
.
Summary
A.E. Kublschkaya, L.R. Musabaeva
Determination of clonidine (clonidine) in forensic practice
The article presents data on the properties and methods of diagnosis of poisoning caused by
clonidine.

: 591.4:612.017.1:546.18-615.099.2


2011, 7 (102)

..



- . .. , .

, , () [1, 2, 3].
, [4, 5, 6, 7].

[8, 9].
:
.
51

.
50 - 150180 .

. 2
,
.
(/) . 0,1%
0,20,3 .
( 3 , 0,5 /) .
7, 14, 21, 30- .
10%
(70%, 80%, 96%, 96%, 96%) . 58 ,
. -
2,5% 1% . JEM-100.
.
,

. ,
. , , .

.
, .
, .
,
, .
, ,
, .
7 ,
, .
.
.
, ,
.
52

,
, .
,
. , , ,
.

. -
,
. , ,
,
.
. 21-
,
,
. , ,
.
, . ,
.
, , ,
, ,
.
, .
.
- ( ) ,
. , , .
. ,
.
,
. .
.
.
30-

53

.
,
, , .
, .
.
.
,
.
-
,
- .
,
.
, . . ,
.
,
,
.
, , .
,
,
. , ,
. , , , .
. ,
,
. . ,

8- 28,7% .
,
. -
,
54

. .

1. .., .. .
, . . . . -, 1982. . 105107.
2. ..
- . . . . -, 1983, 24 .
3. .. . . .
. ., 1984.
4. .. . . . . -, 1992. . 50.
5. .. .
. 1994. 377 .
6. .. . . 1994. 4. . 6264.
7. .. - .
. . . -, 1993. 40 .
8. .., .. . , . 2, 2006.
. 1316.
9. .., .., .. . , . . 2008. 3. . 139143.

..



.

..




.
Summary
A.N. Temirbekov
The study of structural changes in the central organ
of the immune system thymus
in chronic toxicity of phosphoric
The article presents the results of a study of the ultrastructural morphological changes in the
thymus of chronic poisoning with yellow phosphorus.
55



2011, 7 (102)

618.2
..


-
,

- . , 20022005
7 .
,
[1].
, .
[24].
() ,
. - 735% ,
.
[5].
,
. , [6, 7].
. - .
135 , .
, II : 14 , 2224 .
, (), - () .
01, ( 16 / 18) - ().
. 27 (45%) ( ). 33 (55%) ( ),
-500000 14 per rectum
: 1 12 10 (20 ), 1
12 (10 ).

: (n=45 ) , ; (n=16 ) , ; (n=14
56

) , . ( , ) 3 6 ; 1 ( , ).

.
.
1014
. HPV 2- .

.
. 9 (27,3%),
-500000 ( ).
.
, ,
3 , 11,1%. 7 (25,9%), , ( < 50%) IgG,
. , -500000 ,
. .
-500000 - - 14 2,5
,
.
.
( , , ),
3 6 61 (81,3%) . 18,3 .
. 8 (10,7%) ,
, . .
.
,
. .

1. .. - , .//. ... ., 2005. 105 .
2. .., .. .//.
2002. . 4. 1. . 46.
3. .., .., .. . .// . 2001. . 2. 2. . 110116.
4. .., .. : . .: . 2002. . 352.
57

5. Anzivino E., Fioriti D., Mischitelli M. et al. Herpes simplex virus infection in pregnancy and in
neonate: status of art of epidemiology, diagnosis, therapy and prevention.//Virology Journal. 2009.V.
6. 40.P. 111.
6. .., .., ..
: . : , 2001. 251 .
7. .., .., .., .. -2: .//: ., 2001, 24 .

..

-
. .

618.2


2011, 7 (102)
..


1, .

,
.
, .
6070% 6575% ,
813 , ( .., 2005).

.
, , , , , ,
, , , .
, :
1. .
2. .
3. .
4. .
5. .
6. 16 .
7. , , .
8. .
58

:
1. .
2. .
3. .
4. .
, .
() . ,

, ,
, .
()
1- 48 , - .
2- , .
3- .
746 21.12.2007 .
, .
, .
, (
48 ).

.

.
,
.

(, ).
, , ,
.
18 2433 . 30
, 4 30
13 . 3 :
(0,9 1 ), (59

24 / 3 , 8
/ 45 ).
(
3 ) /
- .
12 28 33 , . 25 35 .
: ,
,
, , - .
12 , .


, - ,
, , .
. 810 . 10 15
. 15 .
, 75% . 16,7% , . 8,3%
,
, , .
11 -.
7
7- . 3 4- .

. , ,
.
710 37,5% 57,1%
,
. 1
2829 .
,

. (30 /) 60

. ,
, .

..


, -
. , , .


2011, 7 (102)

618.3-008.6:616-003.96
..


5, .

() , ,
. ,
.
6,3 .
, 14%
70% - [1, 3, 4]. ,
, , / ( 6872%)
.
: (1824%) ; (1142%); (4050%),
- [2, 4].
(1015%),
(810%), (78%). - ( 12%, 2%), ( 38%) [17].
(12 ) 46 , 1214- . 23 23 ; 34 .

Fe2+ (100 ) (60 ),
.
.
61

. 5 120 II III .
. 1- 60 ,
II ; 2- ( ) 60 , 3540 .
II
(1 ), 2-
3638 ( 1 2 ). 25
39 . 41 (68,3%) 1- 15 (25,0%) 2-
, 19 (31,7%) 45 (75,0%) . - 15 (25,0%) 12 (20,0%) ,
22 (36,7%) 15 (25,0%). 3 (5,0%) 1-
5 (8,3%) 2- .
: - 12 (20,0%)
1- , 15 (25,0%) 2-; 18 (30,0%)
9 (15,0%) ; 3 (5,0%) 2 (3,3%);
25 (41,7%) 29 (48,3%) . - ,
.
, ,
.
.
( , , , , , ) 14 (23,3%) 1- 32 (53,3%) 2- .
38 (63,3%) 16 (26,7%)
1- 2- ; I 18 (24,0%) 26 (65,0%). II
14 (23,3%) 1- 28 (46,7%) 2- .
III
6 (10,0%) 9 (15,0%) , 15 (25,0%) 18 (30,0%) , 1
1- 2 2-, , . 26 (43,3%) 38 (63,3%),
19 (31,7 %) 1- 27 (45,0%) , 5 (8,3%) 8 (13,3%), 3 (5,0%) 5 (8,4%) . II 2 (3,3%) 4 (6,6%) III 1 (1,6%) 3
(5,0%) . , II III .

, ; .
. , (,
, ). 1- 48 (80,0%) 2- 52 (86,7%), 62

12 (20,0%) 8 (13,3%) . 22 (36,7%) 1- 42 (70,0%) 1-


7 , 5- 8 9 .
1- 3190,00,42,
2850,00,89 . . ,
, , 2- (33%).
1- (24%).
, .
.
1. .
2.
.

1. .. . 2000; 2:6:164172.
2. .., .., .. . . 2003; 1:13:1822.
3. .. .
2002; 2:6:2227.
4. .. - --
: . . . . . ,
2005; 24.
5. .., .. .
. 2000; 4:2:260261.
6. .. .//
, . -- 1, 2, 3. 2011. . 9495.
7. Alen L.H. Biological mechanisms that might underlie irons effects on fetal growth and preterm
birth. J Nutr 2001; 131:282:581589.

..


. .

63

618.3


2011, 7 (102)
..

5, .

, , .
. , , ,
,
.
Helicobacter pylori,
.
, ,
. , , : ,
, , , , (, ), ,
[1].
,
.
, . (
, ) , . ,
,
. - , I ,
23 .
.
.
:
;
.
:
;
.
. .
, .
. , , , , ,
, .
64

( 3060 ).
( 11,5 ).
I, III [2].
.
:
, - .
;
. . ,
. ( ), , ,
. , ,
, . Hb .
, .
;

.
.
, , , .
, . , ,
( ,
, , ). .
.
. 25
; , .
. .
. 34
.
: , , . . :
, . , [3].
:
, ;
.
;
( ( Hb), , ( );
Helicobacter pilori;
65

;
pH- .
.
.
, , ,
, , , ( - ), , , .
, , -
. , , . ,
.
35 . , 23 . , , 23
. , .
,
, .

( ). .
, .
, ,
-
. , ,
23 . , [4].

1. Brandt P.A., Nielsen C.V. Job stress and adverse of pregnancy: a causal link or recall bias?//
Am. J. of Epidimiol. 1992. Vol. 135. P. 302311.
2. ..
, .//. . 1995. . XXVII, . 34. . 5456.
3. .. . ., 1996. 300 .
4. ./ . .. . .: -, 2005. 880 .

..

, , .
, , .
66


2011, 7 (102)

618.3
..



1, .

- [1, 2, 3].
, . , ,
[4].
, - - . -
, , , , .
30 1624 .
, ;
; .
26,5 .
88,1%
. (30,0%).

, 4
, (64,3% 15,0% ).
( ,
, ) (31,4%) .
, , 34%
,
,
.
. (57,1%) ,
.
67

, 77,85,6% . II (57,46,7%
20,45,5% , p<0,05). , (9,16,1% 9,44,1%).

(29,66,2)% . (25,95,9)%,
.
,
, , .
- , ,
. ..
. II , -
.
,
. , . .

.
: 200 (5,0 ) 200,0
5% 510 ,
200 / 23 23 .
,
. , . ,
.
, . , .
,
, .
, ,
.
, , .
68

,
.
- . .
.
, .
.
. , .
, , , , .
. : ,
, , , , , ,
.
2829 1 ,
( 0,40,6
0,861,15 ).
,
2 . : ,
, .
.
,
, . , , , ,

. ,
.
:
1. .. : . . . . , 2007, 25 .
2. .. .//. 2002, 245 .
3. .. . ., , 2002, 144 .
4. .., .. .// . 1990. 8. . 35.
69


..


,
.

613.2/.3


2011, 7 (102)
..


, .


, .
,
,
,
. , , , , , , . .

, , .
,

.
,
50 , .. . 15 , . .
2002 .
48 .
, , ,
, .
330 05.08.2003 . -
( ),
.
, , , , , .
:
;
;
;
70

;
.
,

,
, ,
. ( ) - . , , , -
.
1 15
,
.
- .. .
. ,
.
,
-, . ,
, , .
, . -
( ),
.
, .
,
,
, .
RATIONAL: Self
Cooking Centr ( ) Vario Cooking Center () .
.
.
, , , , .
VarioCooking Control
,
, , 71

, ,

. . , .
( , , ) , ,
. , : , , ,
.
, .
,
,
. , , ,
.

..


, . ,
, , .

618.3


2011, 7 (102)

.. , .. , .. ,
. , ..

8, 5, .

, , . ,
, , , , . , ,
,
. 72

-
. .
, . .
25%, 1020% [1].
, (- , , , . .).
(8090%) :
B, Staphylococcus spp., E.coli, Proteus spp., Klebsiella spp., Enterobacter spp.,
Bacteroides spp., Peptostreptococcus spp., G.vaginalis, C.trachomatis.
:
) ,
) ;
) ;
) , (, , ) [2].
,
;
.
:
1) 34- 1012
. : 39 , ,
, , , .
. , .
2) 24- . 3940 , , , .
, 9- ;
3) (57- ).
38 , ,
, 25- .
: , ;
4) : :
) 510 , , . , ,
35 /, , ;
) .
23- , 39 , ( , , , , ),
. ,
, , , 73

, .
.
,
, , , ,
, , , .
:
;
;
.
2448 . , [3, 4].
, . , ,
, . ,
- , , , .
,
.
, , - ,
-
.

1. ... .. , .. , . 10 18, 2002.
2. ./ . .. . .: -, 2005, 880 .
3. .. . .:
, 2004, 120 .
4. .., . .// . 20012002, .1, 1, . 4546.

.. , .. , .. ,
. , ..

, ,
-
- .

74

616-053.2


2011, 7 (102)
..

16, .

, ,
, , (,
),
.
,
.
, .
, .
100 ,
:
IG A
.
.
.
, 12 , .
.
.
.

.
, .
:
( - , ).
( , ).
( ).
, .
.
(DHA, AR17).
IQ.
.
,
: (2).
.
75

.
.
,
.
( ).
,
.
.
:
.
.
- (, )
.
.
( 260270 /),
, .
.
1993 . ( \)
115 15.06.1997 ,
,
.
( ) (1):
1. , .
2. , .
3.
.
4. .
5. , , .
6. , .
7. ,
24 .
8. ,
.
9. - , .
10.
.
,
,
, , .
76

,
,
.

1. 115 15.06.1997 . .
2. ./.. , . . , 2010, 17 .

..


.

616-053.2


2011, 7 (102)
..



2010
7, .

() .
. .
, ,
.
.
, , ,
. , , .
, .
,
. (45 ) - , : , , .

(
), , - ,
.
77


, . - ,
,
.

[1, 2].
, , .
, .
- , , .
, ,
, .
,
, , . , .
2010 2134 , . I 1462 (68,5%), II 641
(30%), III 37 (1,5%).
15, 5 ,
8, 4, 8,
21, 3, 3, 2, . 35, 1
4.
2010 2009 , , , , ,
, ,
. 100 43,9
2009 . 42,5 2010 . , 100 4,6 2,7; 1000 8,8 2,8 2009 2010 .
2010 232 ,
91, 3, 10, 53, 2, 10,
5, 6, 15, 2,
4, . 35, 15,
1 4.
: 3 , 15 , 2036 ,
21, 59.
,
- 2010
.

1. .., .., .. ./ : . . , 2000, 301 .
78

2. - ./ . .. .
., 2006, 608 .

..


2010
- ,
2010 . .


2011, 7 (102)

616-053.2
..


2010
7, .

(69 ),
(1014 ) (1517 ).
, .

. , , .
, .

, ,
. , , , , .

. - , , , , . .
, , . . ,
.
.
- . , ,
79

.
,
, - , , - ,
. . -

. , , ,
, . ,
, . ,
.
, 15- .
.
15 15 . 14 112, 14
026 025.
2010 12 703
. I 3921
(30,9%), II 7745 (61%), III 1014 (8%), III 23 (0,2%).
129 , 39, 121, 12, 152,
81, 25, 163, 5, 12 9 .
2010 2009 , , 3783 3547 , , , , , , - , ,
.
1000 188 2009 . 181
2010 . ,
8 3.
2010 73 , 130
3441 , .
,
- 2010
.

1. .., .., .. ./ : . . , 2000, 301 .
2. - ./ . .. .
., 2006, 608 .
80


..


2010
, - 2010
.
1000 188 2009 .
181 2010 . ,
8 3.

616-053.2


2011, 7 (102)

.. C, .. , ..



. .. , .

()
, , .
1990- . , , ,
, , , , , .
, ,
5 , , , 2 () 2
5 .

, , . . , 37,5 . , 37,5 ,
, , . , ,
, , , .
, 5 ,
, : 3 . ,
, , ,
. (
, , , ) ,
81

,
38,5 .
, , . 50
, 7,5 /. ,
6 , 1
5 . 45 10-
.
5 ,
38,5 , .
, ,
,
.
38,5 , . , ,
25 / 1 , 2
3 5 ; 2
3 , -1 600 000 .
, ,
, , 2 , . ,
2 3 1 (120 5 )
3 5 2 (10 )
( 500 ). , , , ,
, , ,
, .
3 , , ,
; ; .
3

, .
, (), .
, ( ). :
, , ,
2 . , ; 5% 1%
- . , , 6 ; -; 12
82

; ,
. . ,
, ,
.
3 ,
. .
, ,
: 6 50 000 , 6 12
100 000 , 12 5 200 000 .
,
, .

1. ():
2 5 79 .

.. C,, .. , ..


, ; ; , ; ; , .
-
, .


2011, 7 (102)

616-053.2
..

7, .

. ,
.
,
. , , . ,
, . . 1,52 .
, .
83

, .

, .
. ,
1,52 ,
4050 . ,
. 510- ,
, , .

. . .
.
4050 . ,
40 , , .

. , .
,
.
, . , .
, . , , , , , . .,
. ,
.
. ,
, ( ).
. , , .
, , , . ( 7580) , .
, .
.
. . ,
, .
. . , 84

. ,
, .
. . ,
. , , , . 8
, ,
, , . 12
, . , , .
- . .
.
.. , .
1. ; , .
2. .
, .
. .
3. . , , .
4. , . ,
.
,
() ,
, , .

1. .. . ., , 1995.
2. .., .., .. ./ : . . , 2000, 301 .
3. - ./ . .. .
., 2006, 608 .

..

, , , . , , .

85

616-053.2


2011, 7 (102)
..

7, .

,
, . , , .
, . ,
, , . .
, .
,
, , , . 4 .
8.00 8.30,
7.30; () , 11.30; 14.3015.30 , ,
, . . 19.30. , 14.00, : 8.30, 12.0013.00,
16.30; 19.30.
; .
:
14 , , .
. .
.
, ,
. ,
, . . 3- , 6- . 15
, 30 . . .
, , , , , , 2
, , . : , , .

. , - .
. ,
, .
86

.

, - . ,
,
- , .

, . , ,
, , .
.
-, , , ; ; .
, , , .
, , ( , ).
,
. , - , . (. . , , . .)
, ,
.
, , , , . , ,
- .
( 50 ) ,
, . . , .
.
, , . . ,
. , ,
.
(, ),
. ,
, ,
, .

1. .., .. .
2. .., .. .
3. .., .., .. ./ : . . , 2000, 301 .
4. - ./ . .. .
., 2006, 608 .
87


..

, , ,
. ,
, .

616-053.2


2011, 7 (102)
..



, . ,

- , 10 , (, , - ).
,
44,9% 614 .
() .
. .
, , , .
: , , . . ( ), .

( , , ). .
, (pica chlorotica), , , , . .
. 70% .
(, ..), . , IgA .
- . , ,
, , , , , (
) . .
88

, .
, . ,
, .
( ) , , .
.
:
, ;
;
;
;
();
();
.
:
;
();

.
:
Hb 11091 /;
Hb 9071 /;
Hb 7051 /;
Hb 50 / .
:
1- : , . 1,52 . : 3
35 //; 3 7 100120 /; 7 200 /.
2- : , . 36 . : 3 12 //
; 3 7 5060 /; 7 50100 /.
3 : ,
. 710 , , - 710 , 4060 /.

. .
, , ;
(,
), .
(III) () , ,
. , .
89

,
.

:
;
;
;
.
(III) ( ) () ().
.
: , ,
.
. ,
7 , , .
,
. ( ).
14 6 13 . , 52% .
80%
, .
- .
88%, 71,3%, 67%, / 34%, 22%,
15%. . -
88%.
, 25%.

5059 / 15%, 60 / 85% 2,22,410,12/.
. , 84% .
, 9,6%. ,
6,3 /.
/ 34 , . ,
, , ,
- . .
17% 3 , 5 83% . .
.
, 90

.
, , .

1. .. , 2011. . 2447.
2. .., .. . 2007. 28.
3. .., .., .. . 2006. . 1317.
4. .. . .
2005. . 4550.
5. .. . 2007. . 38.

..


. . ,
.

616-053.2


2011, 7 (102)
..



7, .

(, , -). : ,
; . :
, , ,
, , ,
, .
, .
,
, . .
. , .
91

. 1 .
- 2 . . 1 .
. , , ,
.
. , , 3
2 , 1 . ,
312 , 1 ,
1 3 2 , 3 , - 2 .
, , ; .
1 . , , ,

. , - ;
;
; .
,
. ,
, , .
, - ( 5 )
.
,
23 12
. (2 ).
,
. .
: 1 , 2 . : ,
( ). - 3 .
. : ,
( )
23 .
, , . 92


, . :

.
,

.
,
, . : , , ,
.
, .
, 1 . - 2 .
, . , ,
,
.
1 3 , 1 6 .
- 23 . 1 . .
.

1. .. . ., 2003. . 1. 832 ., . 2. 736 .
2. .., .. ., 2005, 154 .
3. .. . ., 2005, 55 .

..


, .
.

93

616-056.3


2011, 7 (102)
.. , ..

LLERGYSCREEN

, .

. , ,
,
.
- . , , , [1]. ,
. , , 1 . 100 000 2008 38,3 42,3 2009 , 10,4 [2].
c ,
. ( )
, [3].
llergyScreen in
vitro - .
( , , 250
, , ,
, ),
, [4].
llergyScreen -
.
.
2011 .
llergyScreen 117 5 66 . 78 ,
12, 17, 25, 5
.
4 :
1 , , , ;
2 , , , ;
3 ;
4 , , .
1 44 , 243 , 321, 49 .
6 :
94

0 (0,000,34 IU/ML);
1 (0,350,69 IU/ML);
2 (0,703,49 IU/ML);
3 (3,517,49 IU/ML);
4 (17,549,9 IU/ML);
5 (50,0-100,0 IU/ML);
6 ( 100,0 IU/ML).
2 .
,
58 (49,5%) , 21 (17,9%), 18 (15,3%), 18 (15,3%) . 21 (17,9%)
0 1 , , (
). , ,
.
(82%) - , , ,
.
, llergyScreen - ,
, (
).
, - .

1. .., .. .// . 2004. 12. . 1719.
2. .. , , 2011 .
3. Kersten, von Wahl, in vitro comprarison of the CLA System (Mast) and the CAP System.
Internist. Praxis 38.
4. Kersten, von Wahl, Lange, C.E. Wenning, J. (2000) Empfehlungen zur in vitro Diagnostik
allergischer Erkrankungen Allergologie 23/6.

.. , ..
LLERGYSCREEN

llergyScreen 117
5 66 , 78 ,
12, 17, 25, 5
. (82%)
- , ,
,
.
95

616.211.615.5 (075.8)


2011, 7 (102)
..



6, .

. 57
[1]. - , -. ,
.

, [13].
, ,
. , , , , , , , .
, , .
, ,
, . ,
,
, .
.
. ,

. ,
, , ,
(, ), .
, .
, () , .
- ,
. - (96

, , ). ,

.
.
.
, . ,
. , , - , , . [4].

.
.
( URGO, ) .
. 53
: 12 , 14
, 15 , , 5
, 7 . 1 16 .
. 3 2 .
.
, 26 , 27 .
.

3 . 1 15 150 ,
15 150 . . 4
( 2
3 ). () , .
, (
).
.
.
,
3-, 7- 14- .
(, ,
, (, -)
, (, ).
. , , ,
.
97


. , , .
14
. C , , , : 23-
, , . (14- )
.
, , ,
68- , 1214 .
, ,
, .
, ,
, ,
, .
. . ( )
,
.

1. .., .. .
(. . 1), 2001. 1. . 45.
2. Sinus and Allergy Health Partnership. Antimicrobial treatment guidelines for acute bacterial
rhinosinusitis. Otolaryngol Head Neck Surg 2000; 123 (Suppl.):. . 132.
3. Pankey G.A., Gross C.W., Mendelsohn M.G. Contemporary diagnosis and management of
sinusitis. Pennsylvania 1997, 150 .
4. .., .., .. . . , 2008. 87(1). . 120124.

..


.
.

98


2011, 7 (102)
616-053.2
..


,

. 10 2 .
75,682% (1).
, 10 .
, ,
, .
:
E. coli 53% ( 41,383,3%)
Proteus spp. 8,5%
Enterococcus spp. 8,5%
K. pneumoniae 8,0%
Enterobacter spp. 5,7%
P. aeruginosa 5,4%
Staphylococcus spp. 3,7%
7,2%
-
. (2).
, , ,
.
.
: , , , , , , .
,
, , , , , ,
.
1,5 2 .. , , , .
45 , . . , , ,
.
99

:
; ;

; , .
(1):
- .
.
.
.
.
.
.
( ; , ).

( , ): 7
500700 , 710 7001000 , 10 1,01,5 .
. , , , , .

- ( 14 ).
14 ,
14
6 .
:
(, , ), 2 3- , , , ().
(3):
6 ,
36
.
3 19 ,
. 16 .

1. .., .., ..
. ., 2006, 66 .
2. .. . . . ., 2009. 36 .
3. .., .. . - . . , 2004, 24 .
100


..


. ,
.

616-053.2


2011, 7 (102)
..



8, .

, 90% .
[1].
,
, .
, [2].

, [3]. , ,
.
. 25
, 2 . 15
7 14 , (,
, ) 1 (50 ) 1 1
. 10 , , .
I II
. . .
. : 710 0,2230,055 /, 1114 0,2320,045 /,
(0,250,60 /) , -, ,
[4].
1 , . , , : (4,90,17),
(5,30,22), <0,001. (47,90,48) (3,2 0,08), <0,001.
101

1
,

(n=10)


(109/)

5,550,39
%

(n=15)

5,70,22

0,1


5,60,22

5,70,14

0,1

2,67 0,21

2,7 0,19

0,1

2,9 0,12

2,4 0,18

0,1

. 0,270,02

0,250,01

0,1

0,250,01

0,240,01

0,1

. 0,140,03

510,79

50,60,62

0,1

51,40,6

52,40,47

0,1

. 2,70,18

2,730,11

0,1

2,910,1

2,850,07

0,1

%
%
%

3,00,37

4,80,28

3,00,18

0,1

3,10,19

2,80,16

0,1

0,150,01

0,1

0,140,02

0,150,01

0,1

4,60,21

0,1

4,90,17

5,30,22**

0,01

. 0,330,02

0,310,01

0,1

0,340,02

0,360,02

0,1

39,90,63

0,1

39,00,68

47,90,48***

0,001

2,40,11

0,1

2,60,01

3,20,08***

0,001

39,40,94

. 2,60,08

: * <0,05; ** <0,01.

2 , , , - (230,2) (371,5), <0,001


, . , Ig (2,40,05), IgG (12,70,001),
<0,05. , , <0,1.
, , (7,10,4), <0,01 (54,22,3), <0,001. ,
(4,80,2).
2




(n=10)


-
-
-

35,50,8

. 0,80,1
%

240,5

. 0,610,01
%

18,30,2

. 0,640,05

102


(n=15)

36,71,4

0,1

0,70,2
261,2
0,790,01
17,40,3
0,650,02

0,1
0,1

36,80,7

38,81,5

0,80,2

0,750,3

230,2

371,5***

0,620,02

1,10,01***

17,70,1

17,91,2

0,640,09

0,640,1

0,1
0,001
0,1

(CD4/CD8 )

1,20,01

1,30,5

0,1

1,20,1

1,90,05***

0,001

34,90,5

371,8

0,1

34,30,6

54,22,3***

0,001

4,40,1

4,80,2

0,1

4,50,4

7,10,4**

0,01

16,51,8

171,5

18,51,1

21,61,6

0,40,01

0,390,19

0,1

0,90,1

2,40,05*

-
Ig

. 0,40,01

0,410,06

1,50,2

0,90,2

0,1
0,1

0,05

Ig

1,30,2

1,50,8

0,1

1,20,3

1,50,7

0,1

Ig G

9,81,4

9,91,5

0,1

9,40,1

12,70,01*

0,05

: * <0,05; ** <0,01; *** <0,001.

6 , :
71,7% , 28,3% 12 . , . ,
, 73,6% 12 , 26,4% 34 .
,
.

1. 3.. .//. 2005. 1. . 1417.
2. .. : .//. 2009. 1. . 5861.
3. .., .. : ,
.// . 2009. 1. . 1015.
4. .., .., .. . . .:
, 2002. .134.

..


.

. -, Ig
, IgG, .
: , , .

103


2011, 7 (102)
.. , .. , .. ,
.. , ..



. .. , .

.
- malnutrition . - - . ,
. .
()
, , -,
, . , , . ,
.
, , - .
, . , , , .. ,
, .
, , , ,
, , , , , . :
, , ,
.
, .

, , , , , ,
, .
, : . , ;
,
; (1, 6, 12) , .
25 : 1 4 3 3 7
. .
104

23 , , I ,
. 3-
(, ), DS: , , , , . ,
1 10 .
(), - (, , ), (, , , ,
, , ).
2-
12 (48%), 3- 6 (24%),
7- 6 (24%), 1 (4%).
, ,
, , ( ). 1
17 ( 68% ), 1,5 5 (20%), 2
1 (4%).
4%.
, 4-
, ( ), .
5
, I , .
1214
, 23 .
:

.

1. .. : , 5- . . ., 2003. 832
., 736 .
2. - ./ . .. .
., 2006. 608 .

.. , . , .. ,
.. , ..


25 : 1 4 3
3 7 . .
23 , , ;
1 ,
; ,
.
105

25 1 3-
. 23
72% , 1 68% .

.


2011, 7 (102)

616.9
..

: , , ,

7, .

, , .
- - [1].
,
6 , [2].
,
90% [3].
, , 200 4 - (-,
-, -, ) 2 - (- ). . ,
(,
), , ,
[4].
, -
, , , .
. , , : , .
, .
, , , ,
. , , , ,
, ,
[5]. . . .
.
,
, , .

. -.
56-
106

. , ,
23 .

. , , 23
( 11,5 2050% ). 36 , , 23
25% . ,
.
, , , .
.
. 4,6 ,
. 714-.
, 25% .
. ,
(, , - . .).
,
[6].
5 : I
; II , , ; III
- ; IV
; V
.
0 48 : (,
); , , ; .
, , .

, , , , .
. , ( 3840 ) .
. , ( ), ,
, ,
, , .
, , , . .
. , , . .
, .
( ,
107

, ), 12 . . , , , , .
,
. , . , ,
. , , . -
, ,
: , . ., .
1030% , 538%
, 35%
;
, [7].
. , ,
, . . 35% .
. -
.
. ,
( 5- )
1214 .
4 .
, ,
.

: , , , , ,
. : 1) ; 2)
; 3) ; 4) -
.
, .
48 [8]. , , , , ,
., ,
, . .
,
, - .
: , , ; : , , , , , 1, 2, 3, , ,
0,25%; : , ; : , , ;
.
108

() III, IV
IV /
(710 ) [9].
,
, . , :
, , , , . , .

1. .. .// . 2004. 4 (8).
2. .., .., .. .//
. . 2002. . 224.
3. .. .// . 2004. . 3. 4. . 112114.
4. .., .., .. . .//. . 2007. 1. . 1721.
5. .., .. .// . 2007. 8. . 1621.
6. .., .., .. . - .// 2002. . 10.
20. . 37.
7. .. (.). . ., 2003.
1040 .
8. .. ,
. . ., 2002, 15 .
9. .., .., .. . , (H1N1 SWL: , , . .
28. ., 2009, 18 .

..
: , , ,

(, , ,
).
, , . , . , .

109


2011, 7 (102)

616-002.5 (574.51)
..


20082010 .
,
. ,


.
, , .
.
.
( ) ( ) , .

34,0% (1003 2949). 200820092010 . 1003
, .
1

2008 .

1824
.

2534
.

3544
.

4554
.

55 >
.

22

61,1

42

64,6

51

77,2

51

75,0

42

68,8

159

53,7

14

38,9

23

35,4

15

22,8

17

25,0

19

31,2

137

46,3

36

100

65

100

66

100

68

100

61

100

296

100

2

2009 .

1824
.

3544
.

4554
.

55 >
.

22

68,7

53

68,8

66

76,7

54

78,3

51

63,7

246

71,5

10

31,3

24

31,2

20

23,3

15

21,7

29

36,3

98

28,5

32

100

77

100

86

100

69

100

80

100

344

100

110

2534


2010 .

1824
.

2534
.

3544
.

4554

55 >

19

55,9

49

62,0

70

78,6

65

84,4

54

63,5

256

70,5

15

44,1

30

38,0

19

21,4

12

15,6

31

36,5

107

29,5

34

100

79

100

89

100

77

100

85

100

363

100

, 1003 3
661 (65,9%), 342 (34,1%). 3544 , , , 3,6 ,
. : 65,9% 19,8%,
100% , - .
,
.
4


20082010 .
S-
.


2008

2009

2010

176

212

231

618

61,5

15

15

23

53

5,4

101

105

103

309

30,9

0,1

0,7

0,6

0,5

0,1

1
1

0,2

296

344

363

1003

100

4 , 61,5%, 2- -
30,9%, 5,4%. 176 2008 231 2010
.
111


1003 , 867 (86,4%), 14
(13,6,0%) . 150 (14,9%), 236 (23,5%) R, 107(10,6%), 212 S (21,1%).
: 137 (13,7%), 184 (18,2%), 113 (11,8%), 103 (10,2%),
124 (12,3%), 97 (9,2%).

1. ..
.
. . . . . ., 2006, 24 .
2. .., .. . . V
. ., 1998. . 100102.
3. .., .., .., .., ..
, . .//.
2010. 2 (17).
4. .., .., .. .//. 2003. 1
(3). . 97100.
5. .. : . . . . . ., 2004. 22 .

..

20082010 .

20082010 . , ,
. .

616.211.615.5 (075.8)


2011, 7 (102)
..


-
5, .

-
. , 40% (13).
.
112

, .
,
. , . , .
, ,
. ,
,
.
, .

.
90% , ,
. ,
, , . .
, 1987 .. , (4).

.

, - .

150 ( Laboratories URG, ). 150
,
. 150 : Mg
; I NaCl ; Zn Se
, .

.
.
,
. , .
, , ,
. :
,
, ;
, , , ;
113

, , ,
( ),
;

.
150, , : 150 450
.
-,
, .

,
, .
. , , .
.
.
.
N , , , .
. .
. 68 ,
7 12 (38 30 ). : (
), ; .
,
. , ,
10- , 1 , 10 . .
: , .
, ,
. 4- : 0 ; 1
; 2 ; 3 .
2 : (35 ) (33 ).
: 2 4 , , 1 4 . 114

.
.
. 68 .
, , ,
. ,
5- (>0,05). 10- , .
,
5- 4,81,3 6,31,6 (<0,05).
.

. ,
(<0,05).

(>0,05).
, , 70%
40% .
74% 50% . ,
, 35% 33% .
. .
. ,
. .
, ,
, , .

1. .., .. .//
, 1995. 3. C. 1016.
2. .. .//
. 1997. 4. . 14.
3. .. .//. ., . . . 1982. 3. C. 3032.
4. .. .//. . . . 1987, 124 .
5. .., .., ..
.// . 2002. 2. . 192193.
6. .., ..
.//. ., . . . 2000. 2. C. 37.
115

7. Bernstein J.M., Dryja D., Murphy T.F. Molecular typing of paired bacterial isolates from
the adenoid and lateral wall of the nose in children undergoing adenoidectomy: implications in acute
rhinosinusitis.//Otolaryngol. Head. Neck. Surg. 2001. Dec. 125(6). . 593597.

..

-
.


2011, 7 (102)

616.1
..



-
.


(),
[1].
. , ,
,
[25].

,
( , , , ,
) , [7].
, , [8].

[9, 10].

- , , 20 . , 2 , 2- .
10 10 , (73,01,83) . 13
. 20 , 7 . 25 . - : I , (); II ,
116

().
: , ,
( , );
, -

. : 10
. 3/ 30 . 3 . : 1 . /, 3 /. ( 10 ).
, 12,
10, , , .

, ( 50 2 /, 40 2 /, 10 2 /,
12,5 ).
20 .
. : () () (
Meditech (-40), ); ( (), () Kem Well, ).
- :
, , ( , ),
; 5- ,
, [9].
t- .
. ,
(), (
) ,
-
. , ,
, , II ,

, (II ) , .
: 20 60%
, ,
, 60%
.
,
117

1 ( 70% 2 , 20% ).
,
, , . ,
. , , - ,
,
. ,
,
( ) , .
,
- , , , , ,
.

1. .. -
.// . .: , 1985. 84 .
2. .., .., .., ..
- .//
. 2000. 1. . 1926.
3. ..
: . . . . . 2006. 133 .
4. .., .. .// / . ..,
.., .. , , 2002. . 6371.
5. .., ..
.// ./ . .. . .: , 2007. . 160180.
6. .., .., .. .
- .// . 1997. 1. . 5156.
7. ..
.// (, , )./ . . .. . : , 2004. . 134164.
8. .., .., .. . . ., 1995 260 .
9. .., .., .. . : . . . , . ., 1983. 69 .
10. ., . , , .//
. 1999. 1. . 58.
118


..


-
(, , ) - (). ,
2 ,
.


2011, 7 (102)

616.1
..

() ,
, , ,
.
1040%,
. ()
1772 % [13].
, ,
. Hildrum B. et al.
2,06 [4]. ,
- - .
Kokubo Y. et al. - 1,75 [95%
I, 1,272,41] 1,9 [95% I, 1,312,77] [5].
Thorn L.M. et al.
- 2 . 10
- 6,3%,
2,7% (p<0,001) [6].
2 36 ,
. Ninomiya JK, et al.
2 7,23 [95% I, 6,228,4]. 3 ,
[7].
130 (91,8% )
.
119

,
2009 : : () 80 94 .
: ( 130/85 . . .), () ( 1,7 /),
( ) (<1,0 / ; <1,2 /
), (
) > 3,0 /, (
6,1 /), ( 2
7,8 11,1 /).

. () ( ).

82 (63,6%). 74,1%,
62,7% .
(=0,31).

.
, , (),
(), (), (), (), (), /, ,
, (), , , .
(), , , , (), , - (),
(), ().
- SCORE , 8,90,5
6,70,5 .
SCORE
, - 31,0%,
69,0% . 46,8% 54,2% (=0,04). SCORE
: 5-9 , 10-14 ,
15 .
.

51,9%
55,8% (=0,62). , ()
,
91,0% 92,0% (=0,84). ,
()
().
120

, () , , ,
, , .
.

, .

. 17,5% 21,0% . ()
53,5%, II ( II) 2,0%, 69,7%,
() 15,2%, () 9,1%, 12,1%. 65,7%, II 3,0%, 65,1%, () 15,1%,
() 12,0%, 12,0%.
. 15,7%
, 35,4% (=0,02).
43,3% 48,6% .
, , , 63,6%. 70 77,8%.
-
, , , , , ,
, ,
, . ,
- .

1. . ., . . .// . 2003. 3. . 3238.
2. .., .., .. - .// . .
. 2003. 12(2). . 8083.
3. Buchanan T.A., Xiang A.H., Peters R.K. et al. Preservation of pancreatic beta-cell function and
prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic
women. Diabetes 2002;51:2796803.
4. Kokubo Y. et al. The Seventh Report of the Joint National Committee on Prevention, Detection,
Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289: 25602572.
5. Thorn L.M. et al. Physical activity and diabetes complications in patients with type 1 diabetes:
The finnish diabetic nephropathy (FinnDiane) study. Diabetes Care31(2):230-232.
6. Hildrum B, Mykletun A, Dahl AA, Midthjell K. Metabolic syndrome and risk of mortality in
middle-aged versus elderly individuals: the Nord-Trndelag Health Study (HUNT). Diabetologia. 2009
Apr;52(4):58390.
7. Ninomiya J.K., LItalien G., Criqui M.H., et al. Association of the metabolic syndrome with
history of myocardial infarction and stroke in the Third National Health and Nutrition Examination
Survey. Circulation. 2004; 109:4246.
121


..


, , , 70 .
- .

616.61


2011, 7 (102)
..

-

,

() - , - .
-
, , 1520%
.
. , 23-
45% ,
100: 100 000. ,
, 1015% . 8% [32].
[16, 27], 15%, 57
, .
, (. .
, ) [4].
,
40%, 3 , [5].
- , . 80% ,
. , ,
.
. ,
.
122

, , .
,
,
.
(8:1),
, .
- , .
,
, ( , , )
9598% . ,
.
,
. 3245% .
.
.
. .
. 270
.
.

270 , .
2009 . - 4717 , 3137 1580
. 147
. 36
, 24,5%. 2010
761 , 270 (35,5%). 73% 27% . 56%
, , , . 28
, 22 .
, , 2
(52,71,1%) ,
.
. 10-
, ,
35- .
, 5-, ,
, , , 92,80,3% 5 100%
123

10 , ,
.

. 50% 60 , 40 20%.
, ,
.
,
,
54%. 67 ,
(44,5 . ).
, .
,
, . , ,
- , - , , .
. ,
. , ,
, . ( 11% ).
,
.
,
. ,

.

1. Hirsch H.A. Pyelonephritis. Stuttgart: S. Karger, 1997; 429 s. Millar L.K., DeBuque L., Wing D.A.
Uterine contraction frequency during treatmtnt of pyelonephritis pregnancy and subsequent in risk of preterm
birth. J Perinatol Medic 2003; 31: 1: 4146.
2. .. : .//. .
. . . 2004. 1. . 1924.
3. .. . . . . 1996. 68:10.
. 5559.
4. Kosinas B.S., Musais S.K., SpargoB.N. et al.//Am. J. Med. 2003. Vol. 75. P. 613617.
5. Warren J., Arbutin E., Heble J. et al.//Clin. Inf. Dis. 2009. Vol. 29. P. 745758.
124


..
-

270 , ,
.

616.1


2011, 7 (102)
..


,

, .

, ( ), - (). , :
-,
, , (), , , ;
-, , , , : ,
, , -
, [2].
- , , [1].
Canadian study, 74%
, 15% , 22% [5].
30 , 35 [2].
, (), ()
,
,
88,1% [6].
,
55 95%.
, ,
.
, 125

[1], ,
. , , [5], , ,
[2].
- . P.S. Klassen,
, : 10 mmHg 12% [6].

[5],
[3], 2,53% [1]. ( 25 50)
, , .
[4].
.
, II 2
, . , II
. ,
II

, [6, 7]. [4],
.
II .

() ,
.
, b-
, [3]. . a [2], ,
[6].
II
[4].
, I1-
, [5].

.

1. .., .., .., ..
.//. 2004. 5. . 102104.
126

2. .. .//. ., . 2000.
3. . 8792.
3. .., .. ( 9- , , , 1113 . 2002 .).//
. 2002. 3. . 1214.
4. Cohen E.P. Hypertension in chronic hemodialysis: viewing a paradox, and some notes on
therapy. Dial & Transplant 2000; 29: 535542
5. Mazzuchi N., Carbonell E., Fernandez-Cean J. Importance of blood pressure control in
hemodialysis patient survival. Kidney Int 2000; 58: 21472154
6. .., .., .. , : .// . 2011. 3.

..

,

, .


2011, 7 (102)

616.24-036.12+616.12-008
..



, .


. (2008 .) .
. , .
. () : () [1, 2, 3]
. .
. 44 36 74 ( 56,4+/8,3 ), 25,
19. 35 ( ) 510 8 .
-, ( /), ,
127

( ) [2]
=(150*)*/ .
0,86, 1,1.
. 186,210,4 . .,
103,77,1 . . ( 1)
24%
9,7%. - , , , ,
, , , .
: 0,760,04,
0,431,1. 14,21,2. ,
.
,
. , ,
, : .
, , ,
[3].

2 , .
:
1.
.
2. , , .
3. .

1. .. .// . - . 2004. .10 4. . 36.
2. - . ., 2004. . 5264.
3. , .
. . . ., 2010.

..


.
128

616.6


2011, 7 (102)
..


UKM, .

(), , / , . 1561 .
Fallopius , XV, .
, , . , .
.
,
, .
0,4% 3,2% 40 70 [1, 2, 4].
:
,
. ,
.
. .
.
/ - . ,
, [3].
.
,
. , ,
, (, ) -, - , .
.
, [5].
20082011 8
46 58 . 1
5 , . 2 (1- )
,
. 2- (6 ) ,
. . ( ), 129

(5 ),
. 2 1,0
. 2
,
, (4 )
1,5 - .
, 2 (1-
) 3 (2- ) . , 1- (20 .).
2 3 . 2 , 10
0,4 / ( BTL-5000). 1%
, . , ( 2- ), , , , .
2- , 1- ,
- (BTL-5000)
20 /2 20 . 6 12-
, ,
, (4 ). (2 ) , .
, , ( ) .

1. ..: ( )
. . . . . ., 2002.
2. Akkus E., Ozkara H., Alici B. et al. Incision and patch graft in the surgical treatment of penile
curvature in Peyronie's disease.//J. European Urology. 2001. Vol. 40. P. 531537.
3. Hrizak H., Marotti M., Gilbert TJ. et al. Normal penile anatomy and abnormal penile conditions:
evaluation with MR imaging.//Radiology. 1988. Vol. 169. P. 683690.
4. Yurkanin J.P., Dean R., Wessells H. Effect of incision and saphenous vein grafting for Peyronie's
disease on penile length and sexual satisfaction.//The journal of Urology. 2001. Vol. 166. P. 17691773.
5. Palmieri A., Imbimbo C., Longo N., Fusco F., Verze P., Mangiapia F., Creta M., Mirone V. A
first prospective, randomized, double-blind, placebo-controlled clinical trial evaluating extracorporeal
shock wave therapy for the treatment of Peyronie's disease.//Eur Urol. 2009;56(2):363.

..

( ) ,
.
130


2011, 7 (102)

616.6
..



UKM, .

, , .
, ,
, . ,
, ,
.
(HPV
human papillomavirus), . (). ,
.
,
( ).
( 8 ),
. ,
.
. .
. 0,5% (), ,
(
).
.
1 ,
.
,
, ,
.

, : , . ,
,
.
131

, .
, , .
, , ,
( ).
, , , . , () ( ).
2008 11 (8 ) 0,5% (3
) , . .
, 3 ,
.
, , , . ,

0,5% . ,
5 . .
5,0 . ,
3,5 , .
( ) -. 10 ,
,
.
6 . 2 .
2- , 3- , .

2 12- , - . 10 (
) -, .
, ,
.
,
. . ( ,
, ) ,
,
.
132


..


. .
( , , )
, , .


2011, 7 (102)

616.61
..

, (),
() ().
()
, , ,

.
, [15].
, ,
, (
),
, . ,
, . .
, , -. ,
[6, 7, 8, 9].
. . 16 .
, ,
, , , 6 ,
, 180/140 . . .
morbi: 1 , ,
.
vitae: , , . ,
133

-: . , .
. / . -
. , . : ,
, . 180/140 . . ., 110 . ,
. . , .
. . , .
: : 65 /, . 1,94, 1,0, 202,
. 7,9, / 73, . 10, 17, 33. : . , . . 1008,
, 2,64./.., . . ., . 12 /., . 1520,
++. . 19500, . 42000, . 1. / .
: . 58,8, 23,3, 596, 213, 173,
. 0,76, 152,6, 59, 5,9,
489, 6,7. : 1,2, 18,7,
2,39. 3,33./.. 1,65 /. 1,15, 0,28,
- 16,87 ( ).
: . . .
: ? . .
. :
.
: , .
. , 01 . .
. , . (110,0
). . : , . .
: .
17, - 3800, 500
-2500, 30 , 14. . ,
. .
, - , ,
- , , ,
.
, , , , .

1. .., .., .. . .:
-, 2002.
2. ./ . ... .: , 2000.
3. ..// . .: . , 2001.
. 299306.
4. Jennette J.C., Thomas D.B.//Nephrol. Dial. Transplant. 2001. V.16, Suppl. 6. P. 8082.
134

5. Pusey C.D.//Kidney Intern. 2003. V.64. P.15351550.


6. .., .., .. . -
: .// . 2005. T. 5. 1. C. 7072.
7. .., .., ..
- .//. . . . 2007.
T. 52. 1. C. 3136.
8. .., .. ./M.: 2007.
332 .
9. .., .., .., ..
./.: -, 2008. 383 .

..


,
.


2011, 7 (102)

616.31
..

[1, 2].

(),
[35].
,
, [6]. (). , ,
. , ,
[79].
,
( ) . 135

,
; ,
; ; .
. 30 . 20 () ( 12 8 ), 9
11 .
2- 10 (), ,
() .
:
; () ,
; , ;
(, ), - (), , .
200 3 30
28 . 57 ,
- () ( 1000 / 100 /). 4
4 .
.
. 9 (38%)
, 19 (58%) ,
, , . 1- 2-
,
, . 80 76,7% 80 80%
.
( ), .

, , .
, , 1 .
24 (80%) 23 (76,6%) ,
25 (83%) 23 (70%), 23 (76,6%) 24 (80%)
1 .
,
, 70% 30% .
30% 10%
136

. 53,3% 3 , 46,6% 46 /
. 40% , 60%
. 30% .
.
20% .
- 4
.

, , .
. , - , 17 (85%)
, 15% ( 2 1 )
.

4 . 5,30,3 5,10,5
.
, (8,10,5 5,60,1 ; p<0,05),
5,80,3 .

.

,
. ,

. , .

, 46,6
43,3% , 40 36,6%, 13,3 13.3%
4 .
, 26 (86,6%) 4- , 24
(80%) 1 . , 2 (6,6%),
(13,3%) 4 , .
.
4-

.
137

, 4- 80% , ,
-
. , ,
, -
,
.
,
. 85%
-,
.
. , ,
:
, , - [10]. , ,

.
, : 86,6%
4 80% . ,
1 , .
:
1.
.
2. -,
.
3. ,
, .
4. 86,6%
, 80% 1
.
5. ,
,
.
138


448 .

1. .. . .: , 2006,

2. .., ..
. . . . 2005.
7 (1). . 27.
3. .. . .
. ., . 2002. 3. . 2534.
4. .. (,
). ., 2002. 20 .
5. .. : , . . . . 2002. 1. . 14.
6. Caldeira M.L., Palombo G. Avaliagao clinica da trimebutine no ilco paralitico postoperatorio.
Folha Med (Bresil) 1980. 81. . 22932.
7. Corazza G.R., Vaira D., Milletti S. et al. Controlled clinical evaluation of pinaverium bromide
and trimebutine in functional disorders of the colon. Acta Therapeutica 1983. 9. . 9. 8. Reynolds J.C.
Prokinetic agents: A key in the future of gastroenterology. Gastroenterol Clin North Am 1989. 18.
. 43757.
9. .., .., .. . , (, ). . . 2000. 17. . 2630.
10. Stotland B.R., Kochman M.B.L. Biliary motility. Cur Opin Gastroenterol 1996. 12 (5). . 90.

..


, ( ) .


2011, 7 (102)
616.33
..
-

, .


,
.
, , . (),
.
, ,
, .
139

4200
- , 1228 (29,2%)
().
. 54,6%,
45,4%. 15 75 . 45,5 .
, (66,0%) 5 , 12,9% 6 10 , 10 21,1% .
, , .
, , , ,
. , , ,
, , , , .
, 2040%
. 10% , 30%,
50% .
: , ,
, , , . ,
27,3% , ,
, . : , , , .
, . 22,6% . , , , ,
, .
. 24,0 %
,

. , .
, , ,
, .
Savary-Miller.
4 (). 83,1%
, , 9,0% , II , 6,9% III , 1,0% IV .

.
, , , .

1. .. .//. 2007. 2. . 4953.
2. .. .. - : . , 2002. 4. . 3644.
140


..
-

, ,
, , , , .

616.3


2011, 7 (102)
..

Helicobacter Pylori

, .


- (), 2080%
, () [1].
10
14%, 635%,
60 80% [2].
, -
75% (40100%)
() - [3].
. - .
.
40 , 20
.
16 70 , 37,5%, 62,5%.
:
-
-, - ,
;
;
, ()
, .
,
. 75% , 37,5%
141

- . ,

, , -, .
40 ( 20 ) , , - 75%. 25% -
.
-
, .

2 : 1- () , 2- () , -
, 1014 .
2 1014- : . 20 12 (60%) , , 3
. 17
-
.
elicobacter pylori
. 90%.
(). 3 (15%) ,
.
, , -, , 1 , 2- 93% .
, , - .
, ,
.

;
4- .
, 1-
,
, 2-
, () .
:
1. , , 142

, -
.
2. .
,
.
, -.

1. .., .., .., .. - .//
Consil. med. (). 2003. 8. . 1620.
2. .. .//.
. ., ., . 2008. 1. . 5968.
3. Raynard B., Nitenberg G. Scbweiz Med Wocbenscbr. 1999; 129 (43): 160512.

..
Helicobacter Pylori

- . - , ,
- 75%. 25% -
.

616.24


2011, 7 (102)
..



, .

, 2020 ()
, [1].
, ,
.
, [6]
102
.
28,2 18,8% ; 6,1 3,5% . , .
,
. ,
143

,
.
.
, ,
,
.
.
, 20072010 . 60
. 30 50 70 ,
67,02,63 . 21 ., 9 .
30 50 70 ,
652,13 . 23 ., 7. [6, 7]. 7
, 19 4.
.
- MMPI .. . (1976). 377 ,
10 3 . 13 -: 3 (L , F , ) 10 (1-
, 2- , 3-
, , 4- , 5-
, 6- , 7-
, 8- , 9- , , 0 ).

SPSS 12.0. , . (-,
- .). () (m).
. F, , ,
. , F
.
F , ,
.
, (5070), 1
( ) ,

, ( ). , 1- 3-
2- ( ).
144

() .
1- 3- , ,
.
.
.
7, 8, 9
, , .
,
. , .
9- ,
, , ,
.
, .
, ,
, ,
. , , .
,
.

1. Lopez A.D., Shibuya K., Rao C. Chronic obstructive pulmonary disease: current burden and
future projections. Eur. Respir J. 2006, 27(2), 397412.
2. .., .., ..
. , -, 1014
2003 . . 131.
3. .., .., ..
. 13- , -, 1014 2003 . . 133.
4. .., .., .. . . 13-
-, -, 1014 2003 . . 133.
5. .., .., .. .
13- , -, 1014
2003 . . 135.

..


,
, , . , .
145

616.24-002.151-06:616.611-002] -091-053-036.1


2011, 7 (102)

.. , . , .. , ..

,

-
. 1919 . . , ,
(6
). , () . 1958 . Stanton J. Tango
. 0,5 1 , ., 1998 . .. , 1984
280 , 21 , 8 13 .
, 10 70 ,
2030-.
: 3040
- .
. : . - , .
,

, ,
- .
, .

. 1. :
- ;
;
; .
146

. 2. :
:
.

. 3. :
-
;
.

. 4. ; ;
; ; .

, , . , .

. -
,
.
147

,
- ,
. -
, Ig G Ig M, 3 4 .
, -
. , . - , LE- .
, , . . , , .
,
, , , , . .
.
(Gause A., 2003; Josse F.G., 2003; Parsons V., 2003).
- , .

1. ., .., - .. . .. . ., , 1983.
2. .. . .
., 1987; 10,136138.
3. .., .. . . 1988;10.141142.
4. .. -
. . . 1996;6;6669.

.. , . , .. , ..

-
, ,
.

148


2011, 7 (102)
616.31
..


, . .

, . ,
. ,
, 4- ,
- , .
, .
, , .
, ,
. , , , , .
[1].
.

, , .

[2].
.

[3].

, , . , ,
. - .

.
149

: , , ,
, , ,
- ( , , , , , , , , ,
, , , , , , ,
),
. , . , , .

. , ,
-.
- , , , , , , , , .
, , .

- XXI .
, , , .
- . , 10- , .
, ( 37 ) [4].
. 35
18 50 :
5 , - 2 ,
11 ,
17 .

: , ,
, , , .
, , ,
, 3,5
4,5 , - . .
.
. , - 1:1, 23 510 .
.
. , ,
150

.

, ,
12- . - 23- ,
45- .
4 , 1
. , , .
. , ,
.

1. .. . ., 2003, 400 .
2. .., .. . . 1998, 360 .
3. . , , .. . ., 2004, 320 .
4. .. . 2001, 15 .

..


,
, ,
, .


2011, 7 (102)
340.6
.. , ..
-

- ( ) ,
,
, . . ,
.
.
.
.
,
, -
.
151

.
-
: , , . , 50
, , 150 2:2:1:1, 0,508 -2
.
4 . ,
. , , 30, 70
.
50 , . 10
1 . : - (1:1)
, ( ) [1], Rf 0,65
(, , ) .
-. (1012) . 5 ,
5
20 . 25% , -
(8:2) 5 , 3 ,
, -
Agilent 6890 Inetrt XL MSD 5975B : DB-1
12 0,2 , - () 1 /,
1:30. : 3 100
, 30 / 310 310 15 . - 275 . 70.
-
, ,
(PMW TOX.1), 5000
[5]. , ,
4,14m/z. . 4,135 ,
4,14 m/z. : 4,16 m/z, 4,18 m/z, 4,38 m/z.
, - , ,
-.

1. .. . - . . 1980. . 95.
2. .. . ., 1976. . 75.
3. .. . ., 1975. . 146.
4. X . . 1968. . 820.
5. Pfleger K., Maurer H., Weber A. Mass Shectrl and GC Data. New York, 1992.
152


.. , ..
-


, .

340.6


2011, 7 (102)
..

-

-5 -5 (-1-) . , , ()
,
1 .
: 0,01 , 0,1 .

.
. 10
.
,
, .


-
: , , [1].
, 25 , .
: 1) ; 2) ; 3) -.
() :
1) --- (25%) (70:40:5) 2) - (9:1).
(). 254 Rf 0,45
( ), : 0,02% 2%
8% . Rf 0,45 , , ,
Rf 0,56 .
153

. [3], 50 90 , 10 10% , , 10% , 1 (


-2 (), ,
. , . 25 10%
, , 25%
-2 . (, , , )
- . .
. 2 , , 1
. 3
- - Agilent 6890 Inetrt XL MSD 5975B
: DB-1 12 0,2 . - 1 /, 1:30. : 3 100 , 30 /
310 310 15 .
- 275 . 70.
- , , (PMW TOX.1), 5000
[4]. , ,

207,00 m/z. .
10,406 .,
207,00 m/z.
: 206,70 m/z, 207,70 m/z 207,00 m/z.
, - : , , ,
,
.

1. .. . ., 1975. . 124151
2. . . 1968. . 900.
3. .. . - .
. 1980. .172178.
4. Pfleger K., Maurer H., Weber A. Mass Shectrl and GC Data. New York, 1992.

..

-
.

154

616.9


2011, 7 (102)
..


, .

, , . ,
, , , , ,
, , . , . , ( ) 130
.
. .
,
. -
. ,
() , , [4].

. ,
.
( , ).
.
, .
[5].
( ).
,
,
- . ,
, , .
2003 - .
.
, , , , , , , ,
[1].
- .
[2].
155

, ; ,
- . , 10
, . , (, ).
, , . ,
, [3].
,
-
, .
,

- .
- ,
.
, , , .
, ,
, .
, ,
.
. ( , )
, .
, ,
.
1.
.
2. .
3. ,
.
4. .
5.
,
.
6. ,
.
156


1. .., . .. .//
. . 1999. . 181182.
2. .., .., .., .. .// . 2007. 3, 117 .
3. .., .., .. .// . 2001. . 294 .
4. - .. .// . ., 2001.
5. .., .. .//. . .
.: , 1985. . 242273.

..


, , .

157



2011, 7 (102)

616-002.5: 616.712
..



, .


, . - , -
.
. ,
, , . .
,
.
, ,
, . . , . - .
-
,
, .
. ,
.
: . ,
, , ,
. , ,
, .
, , ,
, .

158